PTGX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PTGX Market Cap History PTGX YTD Return |
PTGX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PTGX Market Cap History PTGX YTD Return |
PTGX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+20.09% CAGR Mouse over chart for data details
|
PTGX Stock Price Chart |
About Protagonist Therapeutics Inc |
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with various peptide-based new chemical entities in different stages of development, all derived from Co.'s proprietary technology platform. Co.'s clinical programs address two main categories of diseases; hematology and blood disorders, and inflammatory and immunomodulatory diseases. Co.'s main clinical asset, rusfertide (generic name for PTG-300) is an injectable hepcidin mimetic in development for the potential treatment of erythrocytosis, iron overload and other blood disorders. PN-943 is an investigational, orally delivered, gut-restricted alpha-4-beta-7 specific integrin antagonist for inflammatory bowel disease. We show 33 historical shares outstanding datapoints in our coverage of PTGX's shares outstanding history. Understanding the changing numbers of PTGX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PTGX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PTGX by allowing them to research PTGX shares outstanding history as well as any other stock in our coverage universe. |
PTGX Current Stock Quote |
Free PTGX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
PTGX Share Performance |
Shares Outstanding Peers |
Protagonist Therapeutics (PTGX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PTI Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.